Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Non-Current Assets (2016 - 2025)

Ocular Therapeutix has reported Non-Current Assets over the past 13 years, most recently at $25.9 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $25.9 million for Q4 2025, up 52.99% from a year ago — trailing twelve months through Dec 2025 was $86.0 million (up 19.57% YoY), and the annual figure for FY2025 was $25.9 million, up 52.99%.
  • Non-Current Assets for Q4 2025 was $25.9 million at Ocular Therapeutix, up from $23.9 million in the prior quarter.
  • Over the last five years, Non-Current Assets for OCUL hit a ceiling of $25.9 million in Q4 2025 and a floor of $12.7 million in Q2 2022.
  • Median Non-Current Assets over the past 5 years was $18.1 million (2025), compared with a mean of $17.8 million.
  • Biggest five-year swings in Non-Current Assets: soared 71.35% in 2023 and later dropped 17.84% in 2024.
  • Ocular Therapeutix's Non-Current Assets stood at $13.6 million in 2021, then skyrocketed by 44.71% to $19.7 million in 2022, then increased by 0.83% to $19.8 million in 2023, then dropped by 14.51% to $16.9 million in 2024, then soared by 52.99% to $25.9 million in 2025.
  • The last three reported values for Non-Current Assets were $25.9 million (Q4 2025), $23.9 million (Q3 2025), and $18.0 million (Q2 2025) per Business Quant data.